Schedule 13D ownership disclosure

Windtree Therapeutics Inc

Security class unavailable · CUSIP: 97382D204

Event date: 2018-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,336,790
Percent of class
13.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-18-022825
Form type
SC 13D
Filer
Ivy Blue Holdings Ltd
CIK
CIK 1760559
Filed
Dec 31, 2018
Reporting period
Dec 21, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub